Embracing Bayesian Methods in Clinical Trials

This Perspective discusses the importance of the US Food and Drug Administration’s draft guidance on the use of bayesian methods in clinical trials because it underscores its commitment to modernizing clinical research.

Clinical trial: Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis (TAG-MS): A Phase 2, Randomized, Double-Blind, Parallel-Arm Study

https://clinicaltrials.gov/study/NCT07497399?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20315

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Comparison of Gait Metrics in Patients With Stroke, Traumatic Brain Injury, and Multiple Sclerosis Before and After Functional Electrical Stimulation

https://clinicaltrials.gov/study/NCT07492602?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20305

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Comparison of the Performance of the 2024 and 2017 McDonald Criteria for the Diagnosis of Multiple Sclerosis in Real Life

https://clinicaltrials.gov/study/NCT07492667?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20306

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: FACTORS ASSOCIATED WITH URINARY INCONTINENCE AND EVALUATION OF PELVIC FLOOR MUSCLE ACTIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS: CROSS-SECTIONAL STUDY

https://clinicaltrials.gov/study/NCT07489794?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20294

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Comparison of the Effects of Pelvic Floor Strengthening and Relaxation Exercises Delivered Via Telerehabilitation in Women Diagnosed With Multiple Sclerosis: A Randomized Controlled Study

https://clinicaltrials.gov/study/NCT07485556?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20275

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: A Multicenter, Open-label, Single-arm Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Chinese Patients With Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis

https://clinicaltrials.gov/study/NCT07483450?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20262

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology